Table 1.
Baseline characteristics of patients who had AIS
| Demographic characteristics | DM patients |
| N | 568 |
| Age (years), median (IQR) | 65 (55–74) |
| Male gender, n (%) | 377 (66.4) |
| Vascular risk factors, n (%) | |
| Hypertension | 398 (70.1) |
| Atrial fibrillation | 78 (13.7) |
| Hypercholesterolemia | 182 (32.0) |
| Coronary heart disease | 75 (13.2) |
| Previous TIA or stroke | 89 (15.7) |
| Active smoking | 205 (36.1) |
| Clinical findings | |
| BMI (kg/m2), mean±SD | 24.10±2.96 |
| Systolic blood pressure (mm Hg), median (IQR) | 148 (130–166) |
| Diastolic blood pressure (mm Hg), median (IQR) | 83 (75–93) |
| TOAST classification, n (%) | |
| Large-vessel occlusive | 177 (31.2) |
| Small-vessel occlusive | 318 (56.0) |
| Cardioembolic | 56 (9.9) |
| Other and unknown | 17 (3.0) |
| HbA1c (%), median (IQR) | 6.6 (5.8–8.3) |
| FBG (mmol/L), median (IQR) | 7.37 (5.99–10.10) |
| NIHSS score at admission, median (IQR) | 4 (2–10) |
| Reperfusion therapy, n (%) | 32 (5.6) |
| Unfavourable outcome at 3 months, n (%) | 226 (39.8) |
| Mortality at 3 months, n (%) | 58 (10.2) |
AIS, acute ischaemic stroke; BMI, body mass index; DM, diabetes mellitus; FBG, fasting blood glucose; HbA1c, glycated haemoglobin; NIHSS, National Institutes of Health Stroke Scale; TIA, transient ischaemic attack; TOAST, Trial of Org 10 172 in Acute Stroke Treatment.